Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2008-01-10

Clinical Trial Update: Treatment of Depression With Quetiapine [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating quetiapine for major depressive disorder with psychotic features was terminated. The update notes the status but does not provide tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quetiapine (quetiapine)

Snippet

Sponsor: Rush University Medical Center | Conditions: Major Depression With Psychotic Features | Phase 3 | Status: TERMINATED